How much and why is the Artificial Disc Market Growing?

The Artificial Disc market, according to DelveInsight is slated towards a positive market growth due to factors such as the increasing geriatric population, rising prevalence of degenerative disc disorders, a growing number of trauma cases and sports-related injuries, technological advancements and increasing product development activities. Furthermore, lower back pain is considered as one of the chief complaints pointing towards underlying spine-related disorder, increasing the scope of growth for the Artificial Disc market. In addition, to address the shortcomings associated with spinal fusion procedures, spinal non-fusion approaches such as Artificial Discs Replacement are gaining popularity among end-users impacting the growing demand for spinal Artificial Discs in the market globally.

However, on the other hand, limited applicability in patients with advanced bone degeneration and stringent regulatory process for market approval may be certain impeding factors to the Artificial Disc market growth. Also, the sudden outbreak of COVID-19 led to a backlog of surgical procedures and interruption in routine patient care followed by suspension of routine surgeries during the crisis. Also, many health organizations have canceled routine clinical visits to curb the transmission of the virus.


DelveInsight analyzes that Global Artificial Disc Market was valued at USD 1.44 billion in 2020, growing at a CAGR of 11.15% during the forecast period from 2021 to 2026 to reach USD 2.69 billion by 2026.

One of the main drivers of the artificial disc market is the growing geriatric population around the world. Improvements in health facilities and disposable income were key factors in improving quality of life and overall life expectancy. The elderly constitute a large part of the subpopulation susceptible to many diseases and disorders such as degenerative diseases of the spine. For instance, according to the United Nations, World Population Ageing report, in 2020, there were around 727 million people over the age of 65 worldwide. It was also noted that the number of older people is expected to double to more than 1.5 billion in the next three decades. Since the elderly population has a higher risk of bone-related diseases, such as scoliosis, degenerative disc disease, osteoporosis, and other similar diseases. So the demand for artificial disc replacement will increase during the forecast period 2021-2026 which will drive the market growth globally.

As per the research published in the Global Spine Journal, titled “Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide” by Ravindra et al published in 2018, approximately 266 million individuals suffered from degenerative spinal disease and lower back pain each year. The data further mentioned that in 2018, 403 million presented with symptomatic disc degeneration, 103 million with spinal stenosis, and 39 million with spondylolisthesis annually.

Furthermore, lower back pain is considered as one of the chief complaints pointing towards underlying spine-related disorder. According to the research published in the Journal of Hospital Management and Health Policy, titled “Current Epidemiology of Low Back Pain” by Mattiuzzi et al, in 2020, incidence, prevalence and disability-adjusted life years (DALYs) of LBPs are 245.9 million cases per year (15th worldwide cause), 577.0 million cases (15th worldwide cause) and 64.9 million DALYs (6th worldwide cause), respectively. The paper further stated that the risk of LBP is marginally higher in women compared to men. Chronic lower back pain is one of the commonest complaint that may point towards an underlying serious spinal disorder.

The above-stated facts indicate the significant impact the degenerative spine disorders can have on patients’ lives. These indications are associated with a diverse range of clinical symptoms such as weakness, low extremity pain, back pain and can result in the significant reduction in the quality of life.

Surgically, degenerative disc disease is treated by two different approaches- spinal fusion approach results in the fusion of two vertebrae together, thereby limiting the motion of the spine and may cause stiffness and decreased motion of the spine. Therefore, to address the shortcomings associated with the spinal fusion procedures, spinal non fusion approaches such as artificial discs replacement are gaining popularity among end users.


Therefore, there has been a growing demand for spinal artificial discs in the market globally. These devices are gaining popularity as they are designed with the intent to provide stabilization and eliminate pain while preserving motion of the functional spinal unit.

Recently we have been able to see the following movements in this market:

  • In July 2021, Aesculap Implant Systems, LLC announced the long-term reporting from its pivotal trial for the activl® Artificial Disc. 
  • In April 2021, NuVasive Inc. received the product FDA approval for the Simplify® Cervical Artificial Disc for two-level cervical total disc replacement (cTDR).
  • In February 2021, NuVasive Inc. acquired Simplify Medical helping the former expand its product portfolio with the acquisition of the most clinically effective cTDR technology 
  • In March 2018, Orthofix International N.V acquired Spinal Kinetics LLC which helped Orthofix expand their Spine Fixation product portfolio with the inclusion of the Spinal Kinetics M6™ Artificial Discs.

    Read full story here…

Leave a Comment